Amendment to Schedule 13D for Alzamend Neuro, Inc.

This filing is an amendment to Schedule 13D for Alzamend Neuro, Inc., submitted by various reporting persons including Milton C. Ault, III, William B. Horne, Henry C.W. Nisser, Kenneth S. Cragun, and David J. Katzoff. The amendment updates the ownership details and transactions involving the company's common stock and Series B Convertible Preferred Stock. The reporting persons collectively hold significant shares, with Milton C. Ault, III beneficially owning approximately 4.4% of the common stock. The filing also details recent transactions, including conversions of Series B Convertible Preferred Stock into common stock and sales of common stock over the past 60 days. The amendment provides a comprehensive view of the current ownership structure and recent trading activities.